These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 33202406

  • 1. Downregulation of Xeroderma Pigmentosum Complementation Group C Expression by 17-Allylamino-17-Demethoxygeldanamycin Enhances Bevacizumab-Induced Cytotoxicity in Human Lung Cancer Cells.
    Chen JC, Ko JC, Taso YC, Cheng HH, Chen TY, Yen TC, Lin YW.
    Pharmacology; 2021; 106(3-4):154-168. PubMed ID: 33202406
    [Abstract] [Full Text] [Related]

  • 2. 17-(Allylamino)-17-Demethoxygeldanamycin Enhances Etoposide-Induced Cytotoxicity via the Downregulation of Xeroderma Pigmentosum Complementation Group C Expression in Human Lung Squamous Cell Carcinoma Cells.
    Chen JC, Ma PF, Lin YC, Wu CH, Peng YS, Zheng HY, Lin MC, Li YT, Lin YW.
    Pharmacology; 2018; 102(1-2):91-104. PubMed ID: 29953987
    [Abstract] [Full Text] [Related]

  • 3. HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells.
    Ko JC, Chen HJ, Huang YC, Tseng SC, Weng SH, Wo TY, Huang YJ, Chiu HC, Tsai MS, Chiou RY, Lin YW.
    Regul Toxicol Pharmacol; 2012 Dec; 64(3):415-24. PubMed ID: 23069143
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of thymidine phosphorylase expression by using an HSP90 inhibitor potentiates the cytotoxic effect of cisplatin in non-small-cell lung cancer cells.
    Weng SH, Tseng SC, Huang YC, Chen HJ, Lin YW.
    Biochem Pharmacol; 2012 Jul 01; 84(1):126-36. PubMed ID: 22480737
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of ERK1/2 and AKT-mediated X-ray repair cross-complement group 1 protein (XRCC1) expression by Hsp90 inhibition enhances the gefitinib-induced cytotoxicity in human lung cancer cells.
    Tung CL, Jian YJ, Syu JJ, Wang TJ, Chang PY, Chen CY, Jian YT, Lin YW.
    Exp Cell Res; 2015 May 15; 334(1):126-35. PubMed ID: 25662161
    [Abstract] [Full Text] [Related]

  • 6. Lectin, Galactoside-Binding Soluble 3 Binding Protein Promotes 17-N-Allylamino-17-demethoxygeldanamycin Resistance through PI3K/Akt Pathway in Lung Cancer Cell Line.
    Woo JK, Jang JE, Kang JH, Seong JK, Yoon YS, Kim HC, Lee SJ, Oh SH.
    Mol Cancer Ther; 2017 Jul 15; 16(7):1355-1365. PubMed ID: 28336809
    [Abstract] [Full Text] [Related]

  • 7. 17-Allylamino-17-Demethoxygeldanamycin and the Enhancement of PS-341-Induced Lung Cancer Cell Death by Blocking the NF-κB and PI3K/Akt Pathways.
    Lee KH, Jang AH, Yoo CG.
    Am J Respir Cell Mol Biol; 2015 Sep 15; 53(3):412-21. PubMed ID: 25633180
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of p38 MAPK-dependent excision repair cross-complementing 1 expression decreases the DNA repair capacity to sensitize lung cancer cells to etoposide.
    Tsai MS, Weng SH, Chen HJ, Chiu YF, Huang YC, Tseng SC, Kuo YH, Lin YW.
    Mol Cancer Ther; 2012 Mar 15; 11(3):561-71. PubMed ID: 22053010
    [Abstract] [Full Text] [Related]

  • 9. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Teng X, Fan XF, Li Q, Liu S, Wu DY, Wang SY, Shi Y, Dong M.
    Oncol Rep; 2019 Mar 15; 41(3):1875-1882. PubMed ID: 30628719
    [Abstract] [Full Text] [Related]

  • 10. Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells.
    Ko JC, Syu JJ, Chen JC, Wang TJ, Chang PY, Chen CY, Jian YT, Jian YJ, Lin YW.
    Basic Clin Pharmacol Toxicol; 2015 Dec 15; 117(6):383-91. PubMed ID: 26046675
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of rapamycin-induced Akt phosphorylation by cotylenin A correlates with their synergistic growth inhibition of cancer cells.
    Kasukabe T, Okabe-Kado J, Haranosono Y, Kato N, Honma Y.
    Int J Oncol; 2013 Feb 15; 42(2):767-75. PubMed ID: 23255002
    [Abstract] [Full Text] [Related]

  • 12. Sulforaphane potentiates the efficacy of 17-allylamino 17-demethoxygeldanamycin against pancreatic cancer through enhanced abrogation of Hsp90 chaperone function.
    Li Y, Zhang T, Schwartz SJ, Sun D.
    Nutr Cancer; 2011 Feb 15; 63(7):1151-9. PubMed ID: 21875325
    [Abstract] [Full Text] [Related]

  • 13. Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cells.
    Tung CL, Chiu HC, Jian YJ, Jian YT, Chen CY, Syu JJ, Wo TY, Huang YJ, Tseng SC, Lin YW.
    Exp Cell Res; 2014 Apr 01; 322(2):345-54. PubMed ID: 24530475
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo.
    Lang SA, Klein D, Moser C, Gaumann A, Glockzin G, Dahlke MH, Dietmaier W, Bolder U, Schlitt HJ, Geissler EK, Stoeltzing O.
    Mol Cancer Ther; 2007 Mar 01; 6(3):1123-32. PubMed ID: 17363505
    [Abstract] [Full Text] [Related]

  • 15. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
    Babchia N, Calipel A, Mouriaux F, Faussat AM, Mascarelli F.
    Invest Ophthalmol Vis Sci; 2008 Jun 01; 49(6):2348-56. PubMed ID: 18281615
    [Abstract] [Full Text] [Related]

  • 16. Heat shock protein 90 inhibitor 17-AAG down-regulates thymidine phosphorylase expression and potentiates the cytotoxic effect of tamoxifen and erlotinib in human lung squamous carcinoma cells.
    Ko JC, Chen JC, Hsieh JM, Tseng PY, Chiang CS, Liu LL, Chien CC, Huang IH, Chang QZ, Mu BC, Lin YW.
    Biochem Pharmacol; 2022 Oct 01; 204():115207. PubMed ID: 35961402
    [Abstract] [Full Text] [Related]

  • 17. 17-Allylamino-17-demethoxygeldanamycin and ritonavir inhibit renal cancer growth by inhibiting the expression of heat shock factor-1.
    Sato A, Asano T, Ito K, Asano T.
    Int J Oncol; 2012 Jul 01; 41(1):46-52. PubMed ID: 22470109
    [Abstract] [Full Text] [Related]

  • 18. ATP analog enhances the actions of a heat shock protein 90 inhibitor in multiple myeloma cells.
    Cervantes-Gomez F, Nimmanapalli R, Gandhi V.
    J Pharmacol Exp Ther; 2011 Nov 01; 339(2):545-54. PubMed ID: 21821695
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel.
    Sawai A, Chandarlapaty S, Greulich H, Gonen M, Ye Q, Arteaga CL, Sellers W, Rosen N, Solit DB.
    Cancer Res; 2008 Jan 15; 68(2):589-96. PubMed ID: 18199556
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells.
    Ohba S, Hirose Y, Yoshida K, Yazaki T, Kawase T.
    J Neurosurg; 2010 Jan 15; 112(1):33-42. PubMed ID: 19408974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.